Replik auf den „Letter to Editor: Series of articles by T. Bertsch and G. Erbacher culminating in Lipoedema – myths and facts, Part 5: European Best Practice of Lipoedema – Summary of the European Lipoedema Forum Consensus“

Tobias Bertsch; Gabriele Erbacher

doi:10.1055/a-1302-9212

Phlebologie, Table of Contents

Phlebologie 2021; 50(01): e14-e20
DOI: 10.1055/a-1302-9212

Leserbrief

Replik auf den „Letter to Editor: Series of articles by T. Bertsch and G. Erbacher culminating in Lipoedema – myths and facts, Part 5: European Best Practice of Lipoedema – Summary of the European Lipoedema Forum Consensus“

Authors

Tobias Bertsch

Europäisches Zentrum für Lymphologie im Schwarzwald, Földiklinik
Gabriele Erbacher

Europäisches Zentrum für Lymphologie im Schwarzwald, Földiklinik

Abstract

Full Text

References

Literatur
1 Bertsch T, Erbacher G. Response to the Letter to the Editor regarding Lipoedema – myths and facts, Part 1 and Part 5. European Best Practice of Lipoedema – Summary of the European Lipoedema Forum consensus. Phlebologie 2020; 49: 31-49
2 Abrufbar unter: https://lipedema-simplified.org
3 Abrufbar unter: https://lipedemaproject.org
4 Abrufbar unter: https://lipedema-simplified.org/masterclass2020/
5 Abrufbar unter: https://lymfsverige.se/omoss.html
6 Bertsch T, Erbacher G. Lipedema – myths and facts. Part 1. Phlebologie 2018; 47: 84-92
7 Bertsch T, Erbacher G. Lipedema – myths and facts. Part 2. Phlebologie 2018; 47: 120-126
8 Bertsch T, Erbacher G. Lipedema – myths and facts. Part 3. Phlebologie 2018; 47: 188-197
9 Bertsch T, Torio-Padron N, Erbacher G. Lipedema – myths and facts. Part 4. Phlebologie 2019; 48: 47-56
10 Bertsch T, Erbacher G, Corda D. et al Lipoedema: myths and facts, part 5. European best practice of lipoedema – summary of the European Lipoedema Forum consensus. 2020 https://doi.org/10.1055/a-1012-7670
11 Abrufbar unter: http://www.lymfologi.se/lipodem/
12 Bertsch T, Martin KP. Obesity prevalence among lipoedema patients in a lymphological outpatient clinic with statutory health insurance in 2015 (unpublished data).
13 Bosman J. Lipoedema: poor knowledge, neglect or disinterest?. J Lym- phoedema 2011; 6 (02) 109-111
14 Child AH, Gordon KD, Sharpe P. Lipedema: an inherited condition. Am J Med Genet A 2010; 152A (04) 970-976 . https://doi.org/10.1002/ ajmg.a.33313
15 Herbst KL, Mirkovskaya L, Bharhagava A. et al Lipedema fat and signs and symptoms of illness, increase with advancing stage. Arch Med 2015; 7: 10
16 Dudeck JE, Białaszek W, Ostaszewski P. et al Depression and appearance related distress in functioning with lipedema. Psychol Health Med 2018; 23 (07) 846-853 . https://doi.org/10.1080/13548506.2018.1459750
17 Bertsch T, Erbacher G, Elwell R. et al Lipoedema: a paradigm shift and consensus. J Wound Care 2020; 29 (Suppl. 02) S1-S52
18 Erbacher G, Bertsch T. Lipoedema and pain: what is the role of the psyche? Results of a pilot study with 150 lipoedema patients. Phlebologie 2020; 49 (05) 305-316 . https://doi.org/10.1055/a-1238-6657
19 Linsmayer D, Neidlinger PK, Braus DF. Rheuma und Psyche – Eine Kurzübersicht. Orthopäde 2019; 48 (11) 957-962 . doi:10.1007/s00132-019-03812-8
20 Baerwald C, Manger B, Hueber A. Depression als Komorbidität bei rheumatoider Arthritis. Z Rheumatol 2019; 78: 243-248 . https://doi.org/10.1007/s00393-018-0568-5
21 Hofmann P, Hemberger S, Lunzer R. et al Psychische Aspekte der rheumatoiden Arthritis Wie ansprechen? Wie behandeln? Zusammenfassung des Expertenmeetings „Rheuma trifft Psyche“ am 05.11.2015. Abrufbar unter: ttps://www.pfizermed.at/sites/default/files/rheuma_trifft_psyche.pd
22 Bischoff N, Morina N, Egloff N. Chronischer Schmerz bei Traumatisierung. Komplexität und Herausforderung bei Diagnostik und Therapie. PiD – Psychotherapie im Dialog 2016; 17 (04) 69-72 . doi:10.1055/s-0042-116706
23 Viana MC. et al Prior mental disorders and subsequent onset of chronic back or neck pain: findings from 19 countries. J Pain 2018; 19 (01) 99-110 . doi:10.1016/j.jpain.2017.08.011
24 Tegethoff M, Belardi A, Stalujanis E. Comorbidity of Mental Disorders and Chronic Pain: Chronology of Onset in Adolescents of a National Representative Cohort. The Journal of Pain 2015; 16 (10) 1054-1064 . doi:https://doi.org/10.1016/j.jpain.2015.06.009
25 Hooten WM. Chronic Pain and Mental Health Disorders. 2016 Mayo Foundation for Medical Education and Research, Mayo Clin Proc 2016; 91 (07) 955-970
26 Abrufbar unter: https://www.mayoclinicproceedings.org/article/S0025-6196(16)30182-3/pdf
27 Crescenzi R, Marton A, Donahue PMC. et al Tissue Sodium Content is Elevated in the Skin and Subcutaneous Adipose Tissue in Women with Lipedema. Obesity 2017; 26: 310-317 . doi:org/10.1002/oby.22090
28 Ma W, Gil HJ, Escobedo N. et al Platelet factor 4 is a biomarker for lymphatic-promoted disorders. JCI Insight 2020; 5: 13e135109 . doi:10.1172/jci.insight.135109
29 Bertsch T. Obesity-related lymphoedema – underestimated and undertreated. Phlebologie 2018; 47 (02) 75-83
30 Lipedema simplified, webinar: Abrufbar unter. https://lipedema-simplified.org/webinar2020-pf4/ ; hier Minute 14:37-14:47
31 Lohrmann C, Foeldi E, Langer M. MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema. Microvasc Res 2009; 77: 335-339 . doi:org/10.1016/j.mvr.2009.01.005
32 Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C. et al Hallazgos linfogammagráficos en pacientes con lipedema. Rev Esp Med Nucl Imagen Mol 2018; 37: 341-348 . doi:org/10.1016/j.remnie.2018.10.013
33 Shang T, Liang J, Kapron C. et al Pathophysiology of aged lymphatic vessels. Aging 2019; 11 (16) 6602-6613
34 Gould DJ, El-Sabawi B, Goel P. et al Uncovering Lymphatic Transport Abnormalities in Patients with Primary Lipedema. J Reconstr Microsurg 2019; 36: 136-141 . doi:10.1055/s-0039-1697904
35 Abrufbar unter: https://www.pschyrembel.de/Ödem/K0FKR
36 Hirsch T, Schleinitz J, Faerber G. et al Is the differential diagnosis of lipoedema by means of high-resolution ultrasonography possible?. Phlebologie 2018; 47 (04) 182-187
37 Cellina M, Gibelli D, Soresina M. et al Non-contrast MR Lymphography of lipedema. Magent Resonance Imaging 2020; 71: 115-124
38 Reich-Schupke S, Altmeyer P, Stücker M. Thick legs – not always lipedema. J Dtsch Dermatol Ges 2013; 11 (03) 225-233
39 Lipedema – Guidelines in the Netherlands 2014. Abrufbar unter https://www.gdlymph.eu/assets/pdf/Dutch-lipoedema-guideline-2014.pdf
40 Stunkard A. The Results of Treatment for Obesity. A Review of the Literature and Report of a Series. AMA Arch Intern Med 1959; 103 (01) 79-85
41 Bennett W, Gurin J. The Dieter’s Dilemma: Why Diets Are Obsolete–the New Setpoint Theory of Weight Control. New York: Basic Books; 1982
42 Cogan J, Rothblum E. Outcomes of weight-loss Programs. Genetic, Social and General Psychology Monographs 1993; 118: 4
43 Perri MG, Nezu AM, Patti ET. et al. Success and failure in the treatment of obesity: Where do we go from here?. Medicine, Exercise, Nutrition and Health 1995; 4: 255-272
44 Hensrud DD, Weinsier RL. A prospective study of weight maintenance in obese subjects reduced to normal body weight without weight-loss training. American clinical Nutrtion 1994; 60 (05) 688-694
45 Mann T, Tomiyama AJ, Westling E. Medicare’s search for effective obesity treatments: diets are not the answer. Am Psychol 2007; 62 (03) 220-233
46 Nordmann A, Bucher H. Effects of low carb vs low fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Internal Med 2006; 166 (08) 285-293
47 Fildes A, Charlton J. Probability of an obese person attaining normal body weight. American Journal of Public Health 2015; 105 (09) e54-e59
48 Pietiläinen KH, Saarni SE, Kaprio J. Does Dieting Make You Fat?. International J of Obesity 2012; 36 (03) 456-464
49 Bosy-Westhpal A. Effect of weight loss and regain on adipose tissue distribution, composition of lean mass and resting energy expenditure in young overweight and obese adults. Int J Obes (Lond) 2013; 37 (10) 1371-1377
50 Buchwald H, Estok R, Fahrbach K. et al Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256
51 Wittgrove AC, Clark GW. Laparoscopic Gastric Bypass, Roux-en-Y – 500 Patients: Technique and Results, with 3–60 months follow-up. Obes Surg 2000; 10: 233
52 Sugerman HJ, Londrey GL, Kellum JM. et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751-756
53 Rasheid S, Banasiak M, Lipska A. et al. Bypass is an Effective Treatment for Obstructive Sleep Apnea in Patients with Clinically Significant Obesity. Obes Surg 2003; 13: 5
54 Courcoulas AP, Yanovski S, Arterburn DE. et al. Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium. JAMA Surg 2014; 149 (12) 1323-1329
55 Arterburn DE, Olsen M, Maciejewski M. et al. Association Between Bariatric Surgery and Long-term Survival. JAMA 2015; 313 (01) 62-70
56 Sjöström L, Nabro K, Sjöström D. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752
57 Adams TD, Gress R, Hunt S. et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761
58 Shubeck S, Dimmick J, Telem D. Long-term Outcomes Following Bariatric Surgery. JAMA 2018; 319 (03) 302-303
59 Fink JM, Schreiner L, Bertsch T. Leg volume in patients with lipedema following bariatric surgery. Visc Med 2020;